Skip to main content
logo
Mangalam Drugs & Organics Limited (BOM:532637)
India flag India · Delayed Price · Currency is INR
27.00
-0.50 (-1.82%)
At close: Jul 28, 2026

Mangalam Drugs & Organics Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2,3212,3213,1763,6743,7024,509
Revenue Growth
-26.91%-26.91%-13.55%-0.77%-17.89%18.66%
Gross Profit
752.57752.571,4741,2011,1661,408
Operating Income
-323.63-323.63195.6127.98146.34387.99
Net Income
-444-44467.21-90.7212.7196.58
Earnings Per Share
-28.05-28.054.25-5.730.8012.42
EPS Growth
-----93.56%-29.72%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
7.517.5125.8911.8726.8819.55
Total Debt
1,1281,128962.31,070885.47879.04
Net Cash (Debt)
-1,120-1,120-936.41-1,058-858.58-859.5
Net Cash Growth
------
Net Cash Per Share
-70.76-70.76-59.16-66.85-54.24-54.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
41.7841.78425.9439.13395.23257.09
Capital Expenditures
-118.99-118.99-202.01-118.33-279.14-276.69
Free Cash Flow
-77.22-77.22223.93-79.2116.09-19.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
32.42%32.42%46.41%32.71%31.50%31.22%
Operating Margin
-13.94%-13.94%6.16%0.76%3.95%8.61%
Pretax Margin
-20.92%-20.92%1.51%-3.01%0.60%6.15%
Profit Margin
-19.13%-19.13%2.12%-2.47%0.34%4.36%
FCF Margin
-3.33%-3.33%7.05%-2.16%3.14%-0.43%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--17.48-121.958.28
P/FCF Ratio
--5.25-13.34-
PS Ratio
0.180.190.370.400.420.36